Results 271 to 280 of about 5,752,243 (395)
The regulatory effects and applications of TIGIT/CD155 on the tumor microenvironment in HCC
Background The interaction between TIGIT and CD155 compromises immune cell efficacy in tumor targeting, potentially driving hepatocellular carcinoma (HCC) progression through diverse molecular pathways. What Was Done This study investigates the interplay between CD155 and TIGIT in regulating CD8+ T cell function and elucidates its implications in HCC ...
Wenting Li+10 more
wiley +1 more source
A Wolf in Sheep's Clothing: Pseudohypobicarbonatemia in a Patient With Multiple Myeloma. [PDF]
Alahmadi Z, Haq Z, Patel A, King JD.
europepmc +1 more source
Cerebral involvement in multiple myeloma: case report. [PDF]
John J. McCarthy, S.J. Proctor
openalex +1 more source
CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy
Abstract Immuno‐oncology represents an emerging field that has significantly transformed tumor therapeutics, with immune cells serving as the cellular foundations of cancer immunotherapy. Due to its high efficiency and sensitivity, CRISPR/Cas9 genome editing is a highly promising technique for precise and rapid gene modification.
Yuhui Ma+6 more
wiley +1 more source
A CASE OF MINOR ANOMALY TYPE MULTIPLE MYELOMA COMPLICATED WITH PULMONARY EMBOLISM
Tadamasa Tozuka+7 more
openalex +2 more sources
Induction of serum stimulation and plasma cell proliferation during chemotherapy of multiple myeloma [PDF]
JE Karp, PJ Burke, RL Humphrey
openalex +1 more source
Long‐term survival in a dog with suspected primary nodal plasmacytoma treated with surgical excision
Abstract An 8‐year‐old Staffordshire bull terrier presented for left submandibular lymphadenopathy. Cytology showed a monomorphic population of mature plasma cells suggestive of plasma cell neoplasia. On physical examination, no other lymphadenomegaly, cutaneous or oral lesions were found.
Celia Figueroa‐González+4 more
wiley +1 more source